Key result
Uraemia is associated with cardiac hypertrophy independent of hypertension and intermyocardiocytic fibrosis, predisposing dialysis patients to sudden cardiac death and hypotension.
Why the study?
What are the specific cardiac structural changes in uraemia and their clinical implications during dialysis?
What are the specific cardiac structural changes in uraemia and their clinical implications during dialysis?
Uraemic cardiomyopathy involves specific structural changes including blood pressure-independent hypertrophy and intermyocardiocytic fibrosis, which may explain cardiovascular instability during dialysis.
Answers are grounded in this paper and cite their sources.
May guide monitoring for instability in uraemic dialysis; leaves open targeted interventions beyond hypertension control.
In the past, cardiac changes in renal failure have commonly been ascribed to hypertension and poorly specified toxic effects ('uraemic cardiomyopathy'). Our recent experimental and clinical studies suggest (a) that cardiac hypertrophy can be dissociated from hypertension and that blood pressures may have only a permissive role, (b) that experimental uraemia is associated with specific activation of pericytes and intermyocardiocytic fibrosis. Cardiac hypertrophy not correlated with elevated blood pressure, and intermyocardiocytic fibrosis not observed in similarly hypertensive non-uraemic patients, have recently been documented in dialysis patients. The implications of these findings may be (a) electrical instability and predisposition to a sudden cardiac death and (b) diastolic cardiac malfunction with impaired LV filling and predisposition to dialysis hypotension. Some evidence for the latter possibility is provided.
No takes yet. Share an insight, caveat, or question.
Ritz et al. (1990) conducted a review in Uraemia / Renal failure. Uraemia vs. Non-uraemic patients was evaluated on Cardiac hypertrophy and intermyocardiocytic fibrosis. Uraemia is associated with cardiac hypertrophy independent of hypertension and intermyocardiocytic fibrosis, predisposing dialysis patients to sudden cardiac death and hypotension.
Synapse has enriched 10 related papers. Consider them for comparative context: